JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Universal Health Services
UHS
$10.4B
| $153M | 0.02% |
1,206,558
+39,076
| +3% | +$5.39M |
2013 Q2
39 quarters
|
|
|
WBA
627
DELISTED
Walgreens Boots Alliance
WBA
| $153M | 0.02% |
4,429,803
+104,016
| +2% | +$3.69M |
2013 Q2
39 quarters
|
|
628
Invesco S&P 500 Equal Weight ETF
RSP
$95.9B
| $153M | 0.02% |
1,056,732
+351,977
| +50% | +$51.5M |
2013 Q2
39 quarters
|
|
629
General Mills
GIS
$17.1B
| $153M | 0.02% |
1,785,161
+308,135
| +21% | +$24.6M |
2013 Q2
39 quarters
|
|
630
ON Semiconductor
ON
$33B
| $152M | 0.02% |
1,850,863
+523,335
| +39% | +$39.8M |
2013 Q2
39 quarters
|
|
|
FOLD
631
DELISTED
Amicus Therapeutics
FOLD
| $152M | 0.02% |
13,733,485
+186,117
| +1% | +$2.29M |
2015 Q3
30 quarters
|
|
632
Suncor Energy
SU
$81.4B
| $152M | 0.02% |
4,887,018
-538,516
| -10% | -$17.5M |
2013 Q2
39 quarters
|
|
633
Essex Property Trust
ESS
$17.3B
| $151M | 0.02% |
722,289
+29,876
| +4% | +$6.59M |
2013 Q2
39 quarters
|
|
634
CALL
Intuit
INTU
$75.1B
| $151M | 0.02% |
+338,200
| New | +$139M |
2023 Q1
0 quarters
|
|
635
Exelixis
EXEL
$14.5B
| $151M | 0.02% |
7,764,447
-4,755,507
| -38% | -$82.9M |
2016 Q1
28 quarters
|
|
636
Allegro MicroSystems
ALGM
$7.37B
| $150M | 0.02% |
3,134,307
+93,540
| +3% | +$3.81M |
2020 Q4
9 quarters
|
|
637
L3Harris
LHX
$44.1B
| $150M | 0.02% |
764,941
-134,174
| -15% | -$27.4M |
2013 Q2
39 quarters
|
|
638
First Industrial Realty Trust
FR
$7.88B
| $149M | 0.02% |
2,799,425
+1,342,783
| +92% | +$70M |
2013 Q2
39 quarters
|
|
639
iShares Core S&P Small-Cap ETF
IJR
$105B
| $148M | 0.02% |
1,533,893
-395,852
| -21% | -$39.6M |
2013 Q2
39 quarters
|
|
640
MPLX
MPLX
$57.2B
| $148M | 0.02% |
4,298,506
+3,604,755
| +520% | +$124M |
2013 Q2
39 quarters
|
|
641
MKS Inc
MKSI
$18.9B
| $148M | 0.02% |
1,670,174
-242,873
| -13% | -$23.2M |
2013 Q2
39 quarters
|
|
642
National Fuel Gas
NFG
$7.26B
| $148M | 0.02% |
2,556,268
-25,571
| -1% | -$1.48M |
2013 Q2
39 quarters
|
|
|
AMED
643
DELISTED
Amedisys
AMED
| $147M | 0.02% |
1,997,030
+237,160
| +13% | +$20.5M |
2015 Q4
29 quarters
|
|
644
NNN REIT
NNN
$7.86B
| $147M | 0.02% |
3,326,512
-232,983
| -7% | -$10.6M |
2013 Q2
39 quarters
|
|
645
iShares Select Dividend ETF
DVY
$22.3B
| $147M | 0.02% |
1,252,379
-327,494
| -21% | -$39.6M |
2013 Q2
39 quarters
|
|
646
Agnico Eagle Mines
AEM
$93B
| $147M | 0.02% |
2,875,760
+419,355
| +17% | +$21.5M |
2013 Q2
39 quarters
|
|
647
Voya Financial
VOYA
$8.76B
| $147M | 0.02% |
2,050,436
-35,376
| -2% | -$2.48M |
2013 Q2
39 quarters
|
|
648
CALL
Zoetis
ZTS
$28.8B
| $146M | 0.02% |
+879,700
| New | +$144M |
2023 Q1
0 quarters
|
|
649
PUT
State Street SPDR Portfolio Europe ETF
SPEU
$694M
| $146M | 0.02% |
3,254,200
+1,410,500
| +77% | +$52.6M |
2022 Q1
4 quarters
|
|
650
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.2B
| $146M | 0.02% |
1,932,275
+725,272
| +60% | +$54.3M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.